Published on June 20, 2019
“17% of the breast cancer community is Hispanic, but only 1% participate in clinical trials,” says patient advocate and two-time breast cancer survivor Barbara Segarra-Vazquez. How can clinical trial research better reflect the diverse patient population? On-site in Chicago at the 2019 American Society of Clinical Oncology (ASCO) meeting, Barbara discusses her advocacy work making the Hispanic voice heard and promoting inclusivity in research. Barbara also shares advice for self-advocacy and empowerment for those living with breast cancer.
Please remember the opinions expressed on Patient Power are not necessarily the views of our sponsors, contributors, partners or Patient Power. Our discussions are not a substitute for seeking medical advice or care from your own doctor. That’s how you’ll get care that’s most appropriate for you.